Deutsche Bank Ag\ Akouos, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.46 - $5.2 $32,051 - $67,750	-13,029 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.16 - $9.08 $6,414 - $14,001	-1,542 Reduced 10.58%	13,029 $62,000
Q4 2021 Feb 11, 2022	BUY	$7.65 - $11.38 $5,829 - $8,671	762 Added 5.52%	14,571 $124,000
Q3 2021 Nov 04, 2021	SELL	$9.93 - $13.59 $4,379 - $5,993	-441 Reduced 3.09%	13,809 $160,000
Q2 2021 Aug 11, 2021	SELL	$11.87 - $15.96 $19,597 - $26,349	-1,651 Reduced 10.38%	14,250 $179,000
Q1 2021 May 13, 2021	BUY	$13.87 - $21.04 $70,487 - $106,925	5,082 Added 46.97%	15,901 $220,000
Q4 2020 Feb 16, 2021	BUY	$17.03 - $22.45 $52,231 - $68,854	3,067 Added 39.56%	10,819 $214,000
Q3 2020 Nov 12, 2020	BUY	$19.3 - $26.92 $149,613 - $208,683	7,752 New	7,752 $177,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.